Skip to main content
. 2020 Nov 13;10(4):226. doi: 10.3390/jpm10040226

Figure 3.

Figure 3

Treatment response after long-course radiotherapy (LCRT): (a) overall survival (OS) in patients with mucinous adenocarcinoma (MAC); (b) cancer-specific survival (CSS) in patients with MAC; (c) overall survival (OS) in patients with non-mucinous adenocarcinoma (NMAC); (b) Cancer-specific survival (CSS) in patients with NMAC.